Hailey Fe 1.5/30 Kit
Product Images NDC 68462-503

10 FDA label images from Glenmark Pharmaceuticals Inc., Usa · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Hailey Fe 1.5/30 (NDC 68462-503). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Blistercard1

Blistercard1
An instructional diagram for Hailey Fe 1.5/30 oral contraceptive kit showing a 28-day pill calendar arranged in four rows labeled Week 1 to Week 4, with circles representing pill doses for each day of the week from Sunday to Saturday. Arrows indicate the direction to take the pills each week from left to right. Instructions specify starting on Sunday for both Sunday starters and Day-1 starters, with guidance to align the day label strip with the first day of the period for Day-1 starters.*
FDA Label Image

Blistercard2

Blistercard2
An illustrated dosing calendar for Hailey Fe 1.5/30 oral contraceptive kit showing a 4-week pill schedule arranged in rows by week and columns by day (Sunday to Saturday). Instructions indicate to start at the Sunday or Day-1 starter position, with arrows guiding pill-taking direction from left to right each week.*
FDA Label Image

Carton

Carton
Packaging label for Hailey Fe 1.5/30 kit containing Norethindrone Acetate and Ethinyl Estradiol Tablets, USP and Ferrous Fumarate Tablets, USP 1.5 mg/30 mcg. The label notes a 28-day regimen with 3 pouches per carton, each containing one blister of 28 tablets. Manufactured by Glenmark Pharmaceuticals Inc., USA. The label includes dosage, storage instructions, and a barcode.*
FDA Label Image

Eestructure

Eestructure
Chemical structure of Ethinyl Estradiol, an active ingredient in Hailey Fe 1.5/30, showing its molecular framework including hydroxyl groups and an alkyne side chain.*
FDA Label Image

Figure1

Figure1
A forest plot comparing effect estimates from multiple studies on combined oral contraceptive (COC) use versus never use. The left side lists study names and years, the center shows effect size estimates with confidence intervals plotted as dots and lines along an effect estimate axis from -1.5 to 2.0, and the right displays corresponding statistics (OR, RR, HR with confidence intervals). Two main categories are "Ever COC vs. Never COC Use" and "Current COC use vs. Never-Use."*
FDA Label Image
FDA Label Image

Label

Label
Hailey Fe 1.5/30 kit package label showing active ingredients Norethindrone Acetate and Ethinyl Estradiol Tablets USP, and Ferrous Fumarate Tablets USP with strengths of 1.5 mg/30 mcg. Contains 1 blister of 28 tablets in a 28-day regimen. Labeler is Glenmark Pharmaceuticals Inc., USA with manufacturing in India. Each blister includes 21 light green to green tablets and 7 brown to dark brown tablets. Includes storage instructions and contact information.*
FDA Label Image
FDA Label Image

Norstructure

Norstructure
Chemical structure of Norethindrone Acetate, one of the active ingredients in Hailey Fe 1.5/30. The diagram shows the molecular structure with rings and functional groups characteristic of this steroidal compound.*
FDA Label Image

Table2

Table2
A bar chart titled 'Circulatory Disease Mortality Rates Per 100,000 Woman Years by Age, Smoking Status and Oral Contraceptive Use,' showing mortality rate by age groups 15-24, 25-34, 35-44, and 45+, stratified by ever-users (non-smokers and smokers) and controls (non-smokers and smokers). The y-axis measures mortality rates from 0 to 250 deaths per 100,000 woman years.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.